Skip to content
Advertisement

In this Wednesday, Oct. 7, 2020, photo, a Phase 3 Novavax coronavirus vaccine trial volunteer is given an injection at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant) **FILE**

In this Wednesday, Oct. 7, 2020, photo, a Phase 3 Novavax coronavirus vaccine trial volunteer is given an injection at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant) **FILE**

Featured Photo Galleries